Claim Missing Document
Check
Articles

Found 4 Documents
Search

Gambaran Kadar Serum Glutamic Pyruvic Transaminase (SGPT) Pada Penderita Tuberculosis Pengobatan 6 Bulan – 1 Tahun Wa Ode Rustiah; Muawanah Muawanah; Rahmawati Rahmawati; Nurul Ni’ma Azis; Novita Rahman
Lontara Journal of Health Science and Technology Vol 3 No 2 (2022): Ilmu dan Teknologi Kesehatan
Publisher : Lembaga Penelitian dan Pengabdian Masyarakat Politeknik Kesehatan Muhammadiyah Makassar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53861/lontarariset.v3i2.300

Abstract

Tuberculosis (TB) is an infectious disease caused by the bacteria of Mycobacterium tuberculosis. A person who has been diagnosed with active TB (TB that affects the lungs and causes symptoms of coughing up blood, night sweats, weight loss, fever and chest pain), will be given a TB drug package (OAT) that must be taken for six months, where This drug is a combination of several antibiotics. TB treatment is divided into 2 phases, namely the intensive phase (2-3 months) and the continuation phase (4-6 months). The combination of drugs used consists of a combination of the main and additional drugs. In the treatment of TB, OAT is the main type of drug used. The most serious side effect of using OAT is hepatotoxic. Hepatotoxicity is a reaction to exposure to substances that can cause liver damage. Liver function tests can be done through the SGPT test. The type of this research is descriptive, with the aim of providing an overview of the results of determining Serum Glutamic Pyruvic Transaminase (SGPT) levels in TB patients who undergo treatment for 6 months - 1 year, by taking 8 samples of serum from TB patients, using the Kinetic method on the Biochemical Photometer BC153. The results showed that there were 3 samples that had increased levels of SGPT and the other 5 samples did not experience an increase in levels of SGPT (normal). Giving OAT does not significantly cause SGPT levels in tuberculosis patients to increase, but long-term administration of OAT can affect the increase in SGPT in tuberculosis patients.
Program MBKM: Meningkatkan Soft Skills Mahasiswa Program Studi Pendidikan Biologi Novita Rahman; Erwing Erwing; Romi Adiansyah; Astuti Muh. Amin
Al-Nafis: Jurnal Biologi dan Pendidikan Biologi Vol 2, No 2 (2022): Al-Nafis: Jurnal Biologi dan Pendidikan Biologi
Publisher : IAIN Ternate

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46339/al-nafis.v2i2.910

Abstract

Independent campus is the Merdeka Learning Campus Merdeka (MBKM) program organized by the Ministry of Education and Culture. This study aims to determine whether through MBKM the soft-skills of biology education study program students have increased. this research is a type of quantitative descriptive research. data collection techniques in the form of questionnaires distributed to biology education study program students who take part in the MBKM program. The results showed that the existence of MBKM activities had a good impact on improving the hard-skills and soft-skills of students, which could be seen from a number of respondents' answers, namely: 1) the ability to follow the MBKM program online; 2) the ability to adapt to new friends; 3) the ability to discuss, collaborate, provide advice in teams/groups; 4) the ability to use technological media; 5) the ability to analyze problems and solve problems in teams/groups; 6) the ability to make decisions with consideration of comparing opinions with one another; 7) the ability to follow the rules in MBKM activities as an attitude to improve learning discipline, besides that the improvement of hard-skills and soft-skills through the MBKM program can be seen in the Student Report obtained after the MBKM program is completed which lists the competency scores of hard-skills and soft-skills. Keywords: Biology Education Study Program Students, Merdeka Learning Merdeka Campus (MBKM), Soft Skills
Gambaran Kadar Serum Glutamic Pyruvic Transaminase (SGPT) Pada Penderita Tuberculosis Pengobatan 6 Bulan – 1 Tahun Wa Ode Rustiah; Muawanah Muawanah; Rahmawati Rahmawati; Nurul Ni’ma Azis; Novita Rahman
Lontara Journal of Health Science and Technology Vol 3 No 2 (2022): Ilmu dan Teknologi Kesehatan
Publisher : Lembaga Penelitian dan Pengabdian Masyarakat Politeknik Kesehatan Muhammadiyah Makassar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53861/lontarariset.v3i2.300

Abstract

Tuberculosis (TB) is an infectious disease caused by the bacteria of Mycobacterium tuberculosis. A person who has been diagnosed with active TB (TB that affects the lungs and causes symptoms of coughing up blood, night sweats, weight loss, fever and chest pain), will be given a TB drug package (OAT) that must be taken for six months, where This drug is a combination of several antibiotics. TB treatment is divided into 2 phases, namely the intensive phase (2-3 months) and the continuation phase (4-6 months). The combination of drugs used consists of a combination of the main and additional drugs. In the treatment of TB, OAT is the main type of drug used. The most serious side effect of using OAT is hepatotoxic. Hepatotoxicity is a reaction to exposure to substances that can cause liver damage. Liver function tests can be done through the SGPT test. The type of this research is descriptive, with the aim of providing an overview of the results of determining Serum Glutamic Pyruvic Transaminase (SGPT) levels in TB patients who undergo treatment for 6 months - 1 year, by taking 8 samples of serum from TB patients, using the Kinetic method on the Biochemical Photometer BC153. The results showed that there were 3 samples that had increased levels of SGPT and the other 5 samples did not experience an increase in levels of SGPT (normal). Giving OAT does not significantly cause SGPT levels in tuberculosis patients to increase, but long-term administration of OAT can affect the increase in SGPT in tuberculosis patients.
Gambaran Kadar Serum Glutamic Pyruvic Transaminase (SGPT) Pada Penderita Tuberculosis Pengobatan 6 Bulan – 1 Tahun Rustiah, Wa Ode; Muawanah, Muawanah; Rahmawati, Rahmawati; Azis, Nurul Ni’ma; Rahman, Novita
Lontara Journal of Health Science and Technology Vol. 3 No. 2 (2022): Ilmu dan Teknologi Kesehatan
Publisher : Lembaga Penelitian dan Pengabdian Masyarakat Politeknik Muhammadiyah Makassar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53861/lontarariset.v3i2.300

Abstract

Tuberculosis (TB) is an infectious disease caused by the bacteria of Mycobacterium tuberculosis. A person who has been diagnosed with active TB (TB that affects the lungs and causes symptoms of coughing up blood, night sweats, weight loss, fever and chest pain), will be given a TB drug package (OAT) that must be taken for six months, where This drug is a combination of several antibiotics. TB treatment is divided into 2 phases, namely the intensive phase (2-3 months) and the continuation phase (4-6 months). The combination of drugs used consists of a combination of the main and additional drugs. In the treatment of TB, OAT is the main type of drug used. The most serious side effect of using OAT is hepatotoxic. Hepatotoxicity is a reaction to exposure to substances that can cause liver damage. Liver function tests can be done through the SGPT test. The type of this research is descriptive, with the aim of providing an overview of the results of determining Serum Glutamic Pyruvic Transaminase (SGPT) levels in TB patients who undergo treatment for 6 months - 1 year, by taking 8 samples of serum from TB patients, using the Kinetic method on the Biochemical Photometer BC153. The results showed that there were 3 samples that had increased levels of SGPT and the other 5 samples did not experience an increase in levels of SGPT (normal). Giving OAT does not significantly cause SGPT levels in tuberculosis patients to increase, but long-term administration of OAT can affect the increase in SGPT in tuberculosis patients.